958 / 1266
Results
•
Phase 1 portion completed
–
N = 27 patients
–
May 2013 to November 2014
•
Clinical data cut 7 March 2015
•
Duration on study from 9 weeks to 23 months
(ongoing)
•
20 of 27 patients remain on dabrafenib
112
|
|
958 / 1266
Results
•
Phase 1 portion completed
–
N = 27 patients
–
May 2013 to November 2014
•
Clinical data cut 7 March 2015
•
Duration on study from 9 weeks to 23 months
(ongoing)
•
20 of 27 patients remain on dabrafenib
112